Literature DB >> 7607784

Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.

V Calabrese1, R Raffaele, E Cosentino, V Rizza.   

Abstract

The chemical composition of human cerebrospinal fluid (CSF) is considered to reflect brain metabolism. In this study we measured malondialdehyde (MDA) levels and the activity of enzymes involved in antioxidative processes, glutathione reductase and glutathione peroxidase, in human cerebrospinal fluid of multiple-sclerosis (MS) patients and normal healthy volunteers. Our results indicated that the cerebrospinal fluid in MS showed significantly higher endogenous levels of MDA than the control, as well as a much greater resistance to in-vitro stimulation test. In addition, we found the activity of GSH reductase significantly increased, about twice the control values, whereas the activity of glutathione peroxidase was markedly decreased as compared to control values. Our findings suggest that in MS the activity of antioxidant enzymes is modified, and indicates the conceivable possibility of a pathogenic role of oxidative stress in the determinism of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7607784

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  16 in total

1.  Effects of ferrofluid and phytoalexin spirobrassinin on thioflavin-T-based fluorescence in cerebrospinal fluid of the elderly and multiple sclerosis patients.

Authors:  Zdena Kristofikova; Zuzana Gazova; Katarina Siposova; Ales Bartos; Jan Ricny; Jolana Kotoucova; Jana Sirova; Daniela Ripova
Journal:  Neurochem Res       Date:  2014-05-25       Impact factor: 3.996

2.  Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T.

Authors:  Hetty Prinsen; Robin A de Graaf; Graeme F Mason; Daniel Pelletier; Christoph Juchem
Journal:  J Magn Reson Imaging       Date:  2016-06-28       Impact factor: 4.813

3.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

Review 4.  The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.

Authors:  Rachel R Robinson; Alina K Dietz; Asif M Maroof; Reto Asmis; Thomas G Forsthuber
Journal:  Immunotherapy       Date:  2019-02       Impact factor: 4.196

Review 5.  Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.

Authors:  Vittorio Calabrese; Eleonora Guagliano; Maria Sapienza; Mariangela Panebianco; Stella Calafato; Edoardo Puleo; Giovanni Pennisi; Cesare Mancuso; D Allan Butterfield; Annamaria Giuffrida Stella
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

6.  In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.

Authors:  In-Young Choi; Phil Lee; Peter Adany; Abbey J Hughes; Scott Belliston; Douglas R Denney; Sharon G Lynch
Journal:  Mult Scler       Date:  2017-06-01       Impact factor: 6.312

7.  Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine.

Authors:  V Calabrese; G Scapagnini; A Ravagna; R Bella; D A Butterfield; M Calvani; G Pennisi; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

8.  Multiple sclerosis in nurse anaesthetists.

Authors:  U Flodin; A-M Landtblom; O Axelson
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

9.  Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Authors:  Carmen Martínez; Elena García-Martín; Julián Benito-León; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecilla; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

10.  Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.

Authors:  Neveen A Noor; Heba M Fahmy; Faten F Mohammed; Anwar A Elsayed; Nasr M Radwan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.